Istamet 50/1000 contains two antidiabetic agents with distinct mechanisms. Sitagliptin inhibits DPP-4, increasing incretin activity and supporting glucose-dependent insulin release. Metformin reduces hepatic glucose production and improves insulin sensitivity.

Together, these effects target different aspects of glucose regulation and may provide broader control than either medicine alone when combination therapy is appropriate.

Brand: Istamet

Active Ingredients: Sitagliptin 50mg + Metformin 1000mg

Dosage Form: Tablet

Pack Size: 15 tablets

Class: DPP-4 inhibitor / Biguanide

Route: Oral

Use according to the prescribed combination-therapy regimen.